Skip to Primary Navigation

CDC workforce cuts, FDA nomination fuel public health leadership concerns

A photo of the Centers for Disease Control and Prevention logo with CDC in gray metal on a blue background mounted on a wood panel wall.
Photo: Kevin C. Cox/Getty Images

Debates over leadership at the CDC and FDA underscore growing concerns about scientific independence and public trust in health agencies.

Amid deep staffing and leadership losses, the CDC faces growing questions about its capacity to protect public health, as a contentious FDA nomination raises fresh concerns about scientific independence.

The CDC had approximately 30% fewer employees as of May 2026 than before large-scale staffing reductions began, according to reporting by the New

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience